tilray cbd drops review

Karen Cilli is a fact-checker for Verywell Mind. She has an extensive background in research, with 33 years of experience as a reference librarian and educator.

Common Side Effects of CBD

Steven Gans, MD is board-certified in psychiatry and is an active supervisor, teacher, and mentor at Massachusetts General Hospital.

Drowsiness

CBD benefits include the following:

Tilray cbd drops review

Research conducted at the Hospital for Sick Children (SickKids) establishes promising safety and tolerability data for Tilray 2:100 oil for children with drug-resistant epilepsy (DRE) due to Dravet Syndrome

Tilray® 2:100 Product Shows Promise in Canada’s First Pediatric Study of Mixed THC/CBD Medical Cannabis Oil for Children with Drug-Resistant Epilepsy

NANAIMO, BRITISH COLUMBIA – Tilray Inc., a global pioneer in medical cannabis production and distribution, is pleased to announce that a study featuring Tilray 2:100, a medical cannabis oil containing high amounts of cannabidiol (CBD) and conservative amounts of tetrahydrocannabinol (THC), has shown promising results for children with drug-resistant epilepsy (DRE) due to Dravet Syndrome. The findings of the Phase II trial, which was designed and conducted by researchers at the Hospital for Sick Children in Toronto (SickKids), were published today in the peer-reviewed medical journal Annals of Neurology.

A limitation in this study concerns the small number of participants, the majority of whom were already taking a prescribed antiepileptic drug. Tilray donated product for the trial and funded the research. Next steps include additional research with more participants and variable doses of combined THC/CBD.